Subject application of new pre-operation auxiliary chemotherapy in treating cervical carcinoma
- VernacularTitle:宫颈癌术前新辅助化疗疗效观察
- Author:
Yanbing LI
;
Lili HAN
;
Juan LI
- Publication Type:Journal Article
- Keywords:
Uterine cervical neoplasms;
Chemotherapy,adjuvant
- From:
Chinese Journal of Primary Medicine and Pharmacy
2008;15(4):609-610
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the application value of new pre-operation auxiliary chemotherapy(NACT)in treating cervical carcinoma. Methods Two periods of chemotherapy were conducted on 53 cervical carcinoma patients;the chemotherapy projects were PVB and BIP;operation was made two weeks afterwards. Results The total effective rate of NACT was 77.4% ,26.4% of which was complete remission;50.9% of which was partial remission;local carcinoma bulk decreased significantly; the post-operation pathology indicated that there was 3.8% of uterus infiltration and 7.1% of pelvic cavity lymph node metastasis. Those patients received chemotherapy after the operation,all patients were followed up. Conclusion NACT is safe and effective for the pre-operation treatment of cervical carcinoma,which can reduce the carcinoma bulk and increase the successful rate of the operation.